Literature DB >> 23728762

Bilateral endogenous Serratia marcescens endophthalmitis secondary to endocarditis following cardiac surgery.

D A M Lyall1, M E Gregory, J McDonnell, F De Villiers, D Tejwani.   

Abstract

INTRODUCTION: Endogenous endophthalmitis is a sight-threatening condition caused by microorganisms crossing the blood-ocular barrier and inducing profound intraocular inflammation. CASE REPORT: A 65-year-old female experienced bilateral loss of vision after developing infective endocarditis as a complication of combined Bentall procedure and coronary artery bypass grafting. She was diagnosed with bilateral endogenous endophthalmitis secondary to Serratia marcescens. Despite aggressive treatment with intravitreal injections of antibiotics and steroids, intensive topical and systemic antibiotic therapy, there was permanent loss of sight in both eyes.
CONCLUSION: The case highlights the importance of early recognition of the symptoms and signs of endogenous endophthalmitis in any patient with systemic infection by all clinicians and the necessity of prompt ophthalmological referral if a useful level of vision is to be preserved.

Entities:  

Keywords:  Endogenous endophthalmitis; Serratia marcescens; blood–ocular barrier; endocarditis; intraocular inflammation

Mesh:

Year:  2013        PMID: 23728762     DOI: 10.1177/0036933013482647

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  3 in total

1.  Marvelous but Morbid: Infective endocarditis due to Serratia marcescens.

Authors:  Varun K Phadke; Jesse T Jacob
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2016-05

2.  Serratia Marcescens, a Rare and Devastating Cause of Endocarditis: A Case Report and Review of the Literature.

Authors:  Kelly Luttmann; Victoria R Starnes; Michael Haddad; Joan Duggan
Journal:  Cureus       Date:  2022-06-01

3.  Endogenous Serratia marcescens panophthalmitis: A case series.

Authors:  Mark P Breazzano; Gowtham Jonna; Niraj R Nathan; Hilary H Nickols; Anita Agarwal
Journal:  Am J Ophthalmol Case Rep       Date:  2019-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.